These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27978756)

  • 1. Synthesis of Succinimide-Containing Chromones, Naphthoquinones, and Xanthones under Rh(III) Catalysis: Evaluation of Anticancer Activity.
    Han SH; Kim S; De U; Mishra NK; Park J; Sharma S; Kwak JH; Han S; Kim HS; Kim IS
    J Org Chem; 2016 Dec; 81(24):12416-12425. PubMed ID: 27978756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidentate bromhexine drug coordination modes with various transition metal ions: Synthesis, characterization, and in vitro antibacterial and anti-breast cancer activity tests.
    Sayed FN; Omar NR; Mahmoud NF; Mohamed GG
    J Trace Elem Med Biol; 2024 Dec; 86():127502. PubMed ID: 39154510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regioselective Synthesis of Potential Non-Quinonoid Prodrugs of Plasmodione: Antiparasitic Properties Against Two Hemoglobin-Feeding Parasites and Drug Metabolism Studies.
    Cesar-Rodo E; Dupouy B; Häberli C; Strub JM; Williams DL; Mäser P; Rottmann M; Keiser J; Lanfranchi DA; Davioud-Charvet E
    Molecules; 2024 Nov; 29(22):. PubMed ID: 39598657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of New 1,4-Naphthoquinone Fluorosulfate Derivatives and the Study of Their Biological and Electrochemical Properties.
    Aseeva NV; Danilenko NV; Plotnikov EV; Korotkova EI; Lipskikh OI; Solomonenko AN; Erkovich AV; Eskova DD; Khlebnikov AI
    Int J Mol Sci; 2024 Nov; 25(22):. PubMed ID: 39596326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 5-Fluorouracil analogues versus perfluorophenyl ureas as potent anti-breast cancer agents: Design, robust synthesis, in vitro, molecular docking, pharmacokinetics ADMET analysis and dynamic simulations.
    Sroor FM; El-Sayed AF; Mahmoud K
    Bioorg Chem; 2024 Dec; 153():107944. PubMed ID: 39532011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ru(II)-catalyzed selective C-H amination of xanthones and chromones with sulfonyl azides: synthesis and anticancer evaluation.
    Shin Y; Han S; De U; Park J; Sharma S; Mishra NK; Lee EK; Lee Y; Kim HS; Kim IS
    J Org Chem; 2014 Oct; 79(19):9262-71. PubMed ID: 25225782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of anticancer activity of new 4,5,6,7-tetrabromo-1H-benzimidazole derivatives.
    Łukowska-Chojnacka E; Fedorov E; Kowalkowska A; Wielechowska M; Sobiepanek A; Koronkiewicz M; Wińska P
    Bioorg Chem; 2024 Dec; 153():107880. PubMed ID: 39476601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 1,3,4‒oxadiazole Quinazolines as Potential Anticancer Agents: Design, Synthesis, Biological Evaluation, and
    Gujja V; Sadineni K; Koppula SK; Basireddy A; Venkanna B; Gunda SK
    Curr Drug Discov Technol; 2025; 22(1):e090424228867. PubMed ID: 38616757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives.
    Baker RR; Pereira da Silva JR; Smith G
    Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.
    Reece D; Imrie K; Stevens A; Smith CA;
    Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Pd(II)-pincer type complexes as potential antitumor drugs: synthesis, nucleophilic substitution reactions, DNA/HSA interaction, molecular docking study and cytotoxic activity.
    Pavlović S; Petrović B; Ćoćić D; Schreurer A; Sretenović S; Nešić MD; Nišavić M; Maric Z; Stanisavljević I; Ćorović I; Simović Marković B; Maric V; Jovanović I; Radić G; Radisavljević S; Jovanović Stević S
    Dalton Trans; 2024 Nov; 53(46):18560-18574. PubMed ID: 39470017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structural proof of novel oxazolo[5,4-d]pyrimidine derivatives as potential VEGFR2 inhibitors. In vitro study of their anticancer activity.
    Sochacka-Ćwikła A; Regiec A; Czyżnikowska Ż; Śliwińska-Hill U; Kwiecień A; Wiatrak B; Rusak A; Krawczyńska K; Mrozowska M; Borska S; Ratajczak K; Pyra A; Mączyński M
    Bioorg Chem; 2024 Dec; 153():107958. PubMed ID: 39561438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of bromo-naphthoquinone associated with tannic acid in triple negative breast cancer cells.
    Carvalho EP; Pessoa AS; Iano FG; Ribeiro L; Leme B; Borges LF; Sanches MLR; Ximenes VF; Oliveira RC
    Int J Biochem Cell Biol; 2024 Dec; 177():106697. PubMed ID: 39566654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico inspired design of urea noscapine congeners as anticancer agents: Chemical synthesis and experimental evaluation using breast cancer cells and a xenograft mouse model.
    Pragyandipta P; Naik E; Reddy PK; Nayek A; Kantevari S; Naik PK
    Eur J Med Chem; 2025 Jan; 282():117091. PubMed ID: 39602993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antiproliferative activity evaluation of novel α-mangostin derivatives by ROS/MAPK signaling pathway.
    Fredimoses M; Li P; Zhang Y; Jia H; Liu S; Tian J; Nie W; Liu K; Song M; Dong Z
    Bioorg Chem; 2024 Dec; 153():107968. PubMed ID: 39566271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis.
    Yang Y; Chen W; Dong L; Duan L; Gao P
    Clin Transl Oncol; 2024 Oct; 26(10):2488-2502. PubMed ID: 38625495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model.
    Tomlinson E; Ward M; Cooper C; James R; Stokes C; Begum S; Watson J; Hay AD; Jones HE; Thom H; Whiting P
    Health Technol Assess; 2024 Nov; 28(77):1-109. PubMed ID: 39644102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.